Stocks · Health care · Pharmaceutical Preparations

Perspective Therapeutics, Inc.

CATX Clue Score36
United States Fiscal year ends December CIK 0000728387 Results filed 10 Aug 2026

What the insiders did No buying or selling

By person

8 insiders · 0 transactions
0.2×

Johan (Thijs) Spoor holds only 0.2 times base salary in stock. $201.52K of shares against $680.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Johan (Thijs) Spoor last reported holding, valued at $3.15, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Lantheus Holdings, Inc. entity
10% owner
—
—
—
11,563,425
$36.39M
−1.0%
Lantheus Alpha Therapy, LLC entity
10% owner
—
—
—
11,273,364
$35.48M
−3.5%
Lori A Woods
Director
—
—
—
183,460
$577.39K
+14.7%
Robert F Williamson III
Director
—
—
—
118,846
$374.03K
+178.0%
Johan M. Spoor
Chief Executive Officer
—
—
—
64,033
$201.52K
+2,141%
Jonathan Robert Hunt
Chief Accounting Officer
—
—
—
59,800
$188.20K
+66.2%
Juan Graham
Chief Financial Officer
—
—
—
35,354
$111.27K
+1,649%
Heidi Henson
Director
—
—
—
25,975
$81.75K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.